NURIA
GARCÍA MARCHENA
Profesora ayudante doctora
Francisco Javier
Pavón Morón
Publicaciones en las que colabora con Francisco Javier Pavón Morón (30)
2023
-
Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder
International Journal of Molecular Sciences, Vol. 24, Núm. 2
2022
-
Niveles plasmáticos de midkina en pacientes con trastorno por uso de cocaína en abstinencia
Adicciones: Revista de socidrogalcohol, Vol. 34, Núm. 4, pp. 273-277
2021
-
Evaluation of neurotrophic factors and education level as predictors of cognitive decline in alcohol use disorder
Scientific Reports, Vol. 11, Núm. 1
-
Inflammatory factors and depression in substance use disorder
The Neuroscience of Depression: Genetics, Cell Biology, Neurology, Behavior, and Diet (Elsevier), pp. 149-160
-
Inflammatory factors and depression in substance use disorder
The Neuroscience of Depression, 1st Edition: Volume 1-2 (Elsevier), pp. V2-149-V2-160
-
Influence of gender and education on cocaine users in an outpatient cohort in Spain
Scientific Reports, Vol. 11, Núm. 1
-
Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder
Scientific Reports, Vol. 11, Núm. 1
-
Plasma concentrations of lysophosphatidic acid and autotaxin in abstinent patients with alcohol use disorder and comorbid liver disease
Biomedicines, Vol. 9, Núm. 9
2020
-
Abstinent patients with alcohol use disorders show an altered plasma cytokine profile: Identification of both interleukin 6 and interleukin 17A as potential biomarkers of consumption and comorbid liver and pancreatic diseases
Journal of Psychopharmacology, Vol. 34, Núm. 11, pp. 1250-1260
-
Cocaine-induced changes in CX3CL1 and inflammatory signaling pathways in the hippocampus: Association with IL1β
Neuropharmacology, Vol. 162
-
Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 102
-
Potential association of plasma lysophosphatidic acid (LPA) species with cognitive impairment in abstinent alcohol use disorders outpatients
Scientific Reports, Vol. 10, Núm. 1
-
Variation in chemokines plasma concentrations in primary care depressed patients associated with Internet-based cognitive-behavioral therapy
Scientific Reports, Vol. 10, Núm. 1
2019
-
Alcohol-induced cognitive deficits are associated with decreased circulating levels of the neurotrophin BDNF in humans and rats
Addiction Biology, Vol. 24, Núm. 5, pp. 1019-1033
-
Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders
PLoS ONE, Vol. 14, Núm. 3
-
Oleoylethanolamide modulates BDNF-ERK signaling and neurogenesis in the hippocampi of rats exposed to δ9-THC and ethanol binge drinking during adolescence
Frontiers in Molecular Neuroscience, Vol. 12
-
Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants
Neuropharmacology, Vol. 149, pp. 212-220
-
Serotonin is the main tryptophan metabolite associated with psychiatric comorbidity in abstinent cocaine-addicted patients
Scientific Reports, Vol. 9, Núm. 1
2018
-
Higher impulsivity as a distinctive trait of severe cocaine addiction among individuals treated for cocaine or alcohol use disorders
Frontiers in Psychiatry, Vol. 9, Núm. FEB
2017
-
Comorbilidad psiquiátrica y valores plasmáticos de 2-acilgliceroles en consumidores de alcohol en tratamiento ambulatorio. Análisis de las diferencias de género
Adicciones: Revista de socidrogalcohol, Vol. 29, Núm. 2, pp. 83-96